AnalystsSean LaamanSean Laaman's Stock Forecasts
AnalystsSean Laaman
Analyst Ranking
Top 36%
#1799 out of 4995 analysts
Average Return
+15.91%
Win Rate
88%7 out of 8
Risk vs Reward
Poor
Good
Sean Laaman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Resmed IncRMD | +90.17% | $134.65 | $256.07 | 2023-10-26 - 2024-10-25 | Strong Buy |
Beone Medicines LtdONC | +52.26% | $206.01 | $313.67 | 2024-12-02 - 2025-08-22 | Strong Buy |
Beone Medicines LtdONC | +30.05% | $241.20 | $313.67 | 2025-06-26 - 2025-08-22 | Strong Buy |
Axsome Therapeutics IncAXSM | +12.40% | $105.44 | $118.51 | 2025-07-02 - 2025-08-22 | Strong Buy |
Disc Medicine IncIRON | +10.23% | $54.75 | $60.35 | 2025-07-02 - 2025-08-22 | Strong Buy |
Sean Laaman Analyst Color
Get additional color on Sean Laaman's coverage of popular stocks
Sean Laaman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Disc Medicine IncIRON | 2 | Strong Buy | $90.00 | +49.13% | Maintains | 6 days ago |
Exelixis IncEXEL | 1 | Strong Buy | $46.00 | +19.08% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 1 | Strong Buy | $190.00 | +60.32% | Assumes | 2 months ago |
Certara IncCERT | 1 | Hold | $16.00 | +39.49% | Assumes | 2 months ago |
Beone Medicines LtdONC | 2 | Strong Buy | $330.00 | +5.21% | Maintains | 2 months ago |
Alector IncALEC | 1 | Strong Sell | $1.50 | -40.48% | Assumes | 6 months ago |
Resmed IncRMD | 1 | Strong Buy | $169.00 | N/A | Upgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.